Hostname: page-component-5c6d5d7d68-wpx84 Total loading time: 0 Render date: 2024-08-15T04:25:01.731Z Has data issue: false hasContentIssue false

The Platelet α2-Adrenoceptor as a Potential Biological Marker in Depression

Published online by Cambridge University Press:  06 August 2018

Jesús A. García-Sevilla*
Affiliation:
Department of Pharmacology, Faculty of Medicine, University of the Basque Country, Vizcaya, Spain

Extract

Insights into the cellular and molecular mechanisms of action of anti-depressant drugs have led to the study of possible dysfunctions of monoamine neurotransmitter receptors in endogenous depression. Presynaptic receptors play an important role in the regulation of transmitter release from neurons. The major mechanism that regulates the release of noradrenaline appears to be feedback inhibition by the neurotransmitter located in the synaptic cleft. This inhibition is mediated by stimulation of a presynaptic autoreceptor, the inhibitory α2-adrenoceptor. When this is stimulated, further release of noradrenaline is inhibited; therefore, increased autoreceptor sensitivity could result in insufficient neuronal release of noradrenaline, and lead to depression.

Type
II. Biological Aspects
Copyright
Copyright © The Royal College of Psychiatrists 

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

García-Sevilla, J. A., Zis, A. P., Hollingsworth, P. J., et al (1981) Platelet α2-adrenergic receptors in major depressive disorder. Archives of General Psychiatry, 38, 13271333.Google Scholar
García-Sevilla, J. A., Guimón, J., García-Vallejo, P., et al (1986) Biochemical and functional evidence of supersensitive platelet α2-drenoceptors in major affective disorder: Effect of long-term lithium carbonate treatment. Archives of General Psychiatry, 43, 5157.CrossRefGoogle ScholarPubMed
García-Sevilla, J. A., Udina, C., Fuster, M. J., et al, (1987) Enhanced binding of [3H](-)adrenaline to platelets of depressed patients with melancholia: Effect of long-term clomipramine treatment. Acta Psychiatrica Scandinavia, 75, 150157.Google Scholar
García-Sevilla, J. A., Areso, P., Giralt, M. T., et al (1988a) Uncoupling of the platelet α2-adrenoceptor adenylate cyclase system by N-ethylmaleimide and the resulting effect on receptor density and sensitivity. European Journal of Pharmacology, 145, 9195.Google Scholar
García-Sevilla, J. A., Padró, D., Giralt, M. T., et al (1988b) α2-Adrenoceptormediated inhibition of platelet adenylate cyclase and induction of aggregation in major depression: Effect of long-term cyclic antidepressant drug treatment. Archives of General Psychiatry (submitted).Google Scholar
Georgotas, A., Schweitzer, J., McCue, R. E. et al (1987) Clinical and treatment effects on 3H-clonidine and 3H-imipramine binding in elderly depressed patients. Life Sciences, 40, 21372143.CrossRefGoogle ScholarPubMed
Kafka, M. S. & Paul, S. M. (1986) Platelet α2-adrenergic receptors in depression. Archives of General Psychiatry, 43, 9195.Google Scholar
Kanof, D. D., Johns, C., Davidson, M. et al (1986) Prostaglandin receptor sensitivity in psychiatric disorders. Archives of General Psychiatry, 43, 987993.Google Scholar
Meana, J. J. & García-Sevilla, J. A. (1987) Increased α2-adrenoceptor density in the frontal cortex of depressed suicide victims. Journal of Neural Transmission, 70, 377381.Google Scholar
Piletz, J. E., Schubert, D. S. P. & Halaris, A. (1986) Evaluation of studies on platelet alpha2 adrenoreceptors in depressive illness. Life Sciences, 39, 15891616.Google Scholar
Siever, L. J., Kafka, M. S., Targum, S. et al (1984) Platelet alpha-adrenergic binding and biochemical responsiveness in depressed patients and controls. Psychiatric Research, 11, 287302.Google Scholar
Smith, C. B., Hollingsworth, P. J., García-Sevilla, J. A. et al (1983) Platelet alpha2 adrenoreceptors are decreased in number after antidepressant therapy. Progress in Neuro-Psychopharmacology and Biological Psychiatry, 7, 241247.Google Scholar
Submit a response

eLetters

No eLetters have been published for this article.